These observations suggest a previously unanticipated mechanism contributing to the pathophysiology of obesity in which DIO disrupts the uroguanylin gut–brain endocrine axis regulating feeding, energy homeostasis and metabolism. This evidence concerns the gene GUCA2B and Obesity.